课题基金 / 基金详情

Postdoctoral Training Program in Cancer Biology

Postdoctoral Training Program in Cancer Biology
癌症生物学博士后培训项目
批准号:
6915037
负责人:
Stuart A Aaronson
金额:
$23.64万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-06-20 至 2007-05-31

项目摘要

项目成果

Stuart A Aaronson的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该博士后培训计划是 旨在吸引一批有才华的医生和基础研究 科学家,并为他们提供深入的生物培训, 成为癌症研究的独立研究者。广泛的师资队伍 由来自10个部门的34名教师组成, 为学员提供最大的机会,学习最现代的 细胞和分子生物学的方法,并发展他们的培训, 广泛的研究领域,包括细胞信号,发育生物学, 分子流行病学和转化/临床研究。独特的混合 医生和基础研究导师将使学员接触到一个优秀的 结合基础和临床导向的癌症研究。提供 必要的多样性,教师已在这些领域的专业知识招聘 来自Ruttenberg癌症中心,Brookdale分子和 发育生物学,菲什伯格神经生物学中心,研究所 基因治疗和分子医学和10个额外的部门。临床 选择的专业包括Hem/Onc、儿科、内科、GI和外科 成为训练计划的一个组成部分这些临床项目 将是临床研究员的主要资源, 博士后培训。学员将在完成后进入该计划 临床项目培训,或完成博士学位后训练所有 候选人将被要求投入至少三年的培训, 基础癌症研究在整个培训期间,学员将致力于 大约90%的时间用于研究。主要重点和 学员的绝大部分时间将用于在 实验室对一个具体的,个性化的研究项目的指导下, 一个或多个教师的。除了在法官席上工作, 学员将参加每周一次的实验室会议, 他们参加特定部门和机构临床的时间, 研究导向的研讨会,并将参加至少两个教学 在第一年和第二年的培训课程。前进主题 基础和临床研究课程是将 促进临床和基础研究的互动。本专业的领导力 以实验室为基础的癌症生物学博士后培训计划包括一个 精心挑选的指导委员会。在9名教职员工中, 指导委员会4作为其他机构领导人 培训赠款。指导委员会的成员包括 临床和基础研究专业知识,并证明个人成功, 博士后导师。
英文摘要
DESCRIPTION (provided by applicant): This postdoctoral training program is designed to attract a talented group of physician and basic research scientists and to provide them with in-depth biologic training requisite to become independent investigators in cancer research. A broad range of faculty which consist of 34 preceptors from 10 departments has been selected to provide trainees the greatest opportunity to learn the most contemporary methods of cellular and molecular biology and to develop their training in broad areas of research including cellular signaling, developmental biology, molecular epidemiology and translational/clinical research. The unique blend of physician and basic research mentors will expose trainees to an excellent combination of basic and clinically oriented cancer research. To provide the necessary diversity, faculty have been recruited with expertise in these areas from the Ruttenberg Cancer Center, Brookdale Center for molecular and developmental biology, Fishberg Center for Neurobiology, the Institute for Gene Therapy and Molecular Medicine and 10 additional departments. Clinical programs including Hem/Onc, Pediatrics, Medicine, GI and Surgery were selected to be an integral component of the training program. These clinical programs will be major resource for clinical fellows who will participate in postdoctoral training. Trainees will enter this program after completing training in clinical program, or upon completion of Ph.D. training. All candidates will be expected to devote a minimum of three years to training in basic cancer research. Throughout the training period, trainees will devote approximately 90 percent of their time to research. The primary focus and vast majority of the trainee's time will be devoted to working in the laboratory on a specific, individualized research project under the guidance of one or more faculty preceptors. In addition to working at the bench, trainees will participate in weekly laboratory meetings, spend a portion of their time attending specific departmental and institutional clinical and research oriented seminars, and will participate in at least two didactic courses during the first and second years of training. The Advance Topic courses in Basic and in Clinical research are among the activities that will foster clinical and basic research interactions. Leadership for this major laboratory-based postdoctoral training program in cancer biology consists of a carefully selected steering committee. Of the 9 faculty members who serve on the steering committee 4 are serving as leaders of other institutional training grants. Members of the steering committee represent a mix of clinical and basic research expertise with demonstrated individual success as mentors of postdoctoral trainees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessing the impact of WTC dust exposure on prostate cancer recurrence
Regulation of Wnt Pathway Specificity
Defining mechanisms and targets in Wnt addicted human malignancies (PQ22)
Defining mechanisms and targets in Wnt addicted human malignancies (PQ22)
海外基金